Form D · Other
BioConsortia, Inc.
Davis, CA · CIK 0001688416
Offering snapshot reported Apr 20, 2023 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 17, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 20, 2023 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Mar 27, 2019 | Initial | $0 | No comparison | 3 | SEC filing |
| Mar 27, 2019 | Amendment | $8,000,000 | $8,000,000vs Mar 27, 2019 | 3 | SEC filing |
| Mar 13, 2018 | Initial | $10,000,010 | No comparison | 3 | SEC filing |
| Oct 27, 2016 | Initial | $7,999,999 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-479553
Source: Form D, filed Apr 20, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christina Huben | Executive |
| Marcus Meadows Smith | Director, Executive |
| John M. Pasquesi | Director |
| Tamara Tompkins | Director |
Issuer details
Industry: Other (See others in industry)
Address:
279 Consteau Place Suite 100
Davis, CA, 95618
Davis, CA, 95618